Avaxia Biologics Secures $1,243,378 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Avaxia Biologics
  • Mailing Address
    128 Spring Street Lexington, MA 02421
  • Company Description
    Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.